Nanomedicine in Drug Delivery

There is a clear need for innovative technologies to improve the delivery of therapeutic and diagnostic agents in the body. Recent breakthroughs in nanomedicine are now making it possible to deliver drugs and therapeutic proteins to local areas of disease or tumors to maximize clinical benefit while limiting unwanted side effects. Nanomedicine in Drug Delivery gives an overview of aspects of nanomedicine to help readers design and develop novel drug delivery systems and devices that build on nanoscale technologies.

Featuring contributions by leading researchers from around the world, the book examines:

• The integration of nanoparticles with therapeutic agents
• The synthesis and characterization of nanoencapsulated drug particles
• Targeted pulmonary nanomedicine delivery using inhalation aerosols
• The use of biological systems?bacteria, cells, viruses, and virus-like particles?as carriers to deliver nanoparticles
• Nanodermatology and the role of nanotechnology in the diagnosis and treatment of skin disease
• Nanoparticles for the delivery of small molecules, such as for gene and vaccine delivery
• The use of nanotechnologies to modulate and modify wound healing
• Nanoparticles in bioimaging, including magnetic resonance, computed tomography, and molecular imaging
• Nanoparticles to enhance the efficiency of existing anticancer drugs
• The development of nanoparticle formulations
• Nanoparticles for ocular drug delivery
• Nanoparticle toxicity, including routes of exposure and mechanisms of toxicity
• The use of animal and cellular models in nanoparticles safety studies

With its practical focus on the design, synthesis, and application of nanomedicine in drug delivery, this book is a valuable resource for clinical researchers and anyone working to tackle the challenges of delivering drugs in a more targeted and efficient manner. It explores a wide range of promising approaches for the diagnosis and treatment of diseases using cutting-edge nanotechnologies.

Nanoparticles in Drug Delivery Systems. Synthesis and Characterization of Nanoencapsulated Drugs. Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine. Biological Systems for the Delivery of Nanoparticles. Nanodermatology: The Giant Role of Nanotechnology in Diagnosis and Treatment of Skin Disease. Nanoparticles for Drug Delivery of Small Molecules. Nanoparticle Therapies for Wounds and Ulcer Healing. Nanoparticles in Bioimaging. Nanoparticles in Anticancer Drug Delivery. Formulations of Nanoparticles in Drug Delivery. Nanoparticles for Ocular Drug Delivery. Toxicology of Nanoparticles. Animal and Cellular Models for Use in Nanoparticles Safety Study. Index.

Arun Kumar, Ph.D., is an assistant professor in the Department of Medical Laboratory Science and the Department of Biomedical Engineering at the University of Delaware. Dr. Kumar has filled in more than 26 patents on his research related to biosensors and nanotechnology. He has presented his work at more than 60 international conferences worldwide, published more than 35 peer-reviewed research articles and two book chapters, and is an editorial board member of Sensors and Transducers Journal.

Heidi M. Mansour, Ph.D., RPh, is an assistant professor of pharmaceutics and drug delivery at the University of Kentucky College of Pharmacy, a faculty associate at the University of Kentucky Center of Membrane Sciences, and a graduate faculty member at the University of North Carolina-Chapel Hill. She serves on the editorial advisory boards of eight journals in drug delivery and nanomedicine, is a member of the NIH U.S. Pediatric Formulations Initiative New Drug Delivery Systems Aerosols Working Group, and is a delegate to the U.S. Pharmacopeia (USP). Dr. Mansour has published more than 40 peer-reviewed scientific publications, five book chapters, and more than 80 abstracts.

Adam Friedman, MD, FAAD, is an assistant professor of dermatology and physiology/biophysics and serves as director of the Dermatologic Research at the Unified Division of Dermatology of Albert Einstein College of Medicine. Dr. Friedman investigates novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules. He holds several patents and has published more than 80 papers/chapters on his research as well as on a variety of clinical areas in dermatology. Dr. Friedman recently published the first textbook on nanotechnology and dermatology and serves as vice president of the Nanodermatology Society.

Eric Blough, Ph.D., is an assoc